PRGO Perrigo Co Plc

$10.24 +0.84%

Healthcare · Pharmaceutical Preparations

Perrigo Co Plc (PRGO) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $1.4 billion. Shares last traded at $10.24, 64.0% below their 52-week high. Over the past year the stock is down 61.0%. Net profit margin is -33.5%, below the peer median of -0.1%. Revenue declined 2.8% year over year. The shares yield 11.3% in dividends.

Market Cap

$1.4B

Shares Out

138.4M

EPS (TTM)

$-3.07

P/E Ratio

—

P/S Ratio

0.33

P/B Ratio

0.57

Dividend / Share

$1.16

Dividend Yield

11.32%

52-Week High

$28.43

52-Week Low

$9.23

Volume

182,768

Avg Vol (3m)

186,273.27

Performance

-5.97%

-3.49%

+6.17%

-21.25%

YTD

-26.29%

-61.01%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

40.09

SMA (50)

$11.19

SMA (200)

$14.54

Price vs SMA50

-8.47%

Price vs SMA200

-29.53%

ATR (14)

$0.64

Financials

Revenue

$4.3B

Net Income

$-1425M

Gross Margin

35.1%

Operating Margin

-26.4%

Net Margin

-33.5%

Return on Equity

-57.0%

Return on Assets

-17.9%

Current Ratio

2.72

Debt / Equity

1.45

Revenue Growth (YoY)

-2.8%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$-2.87	2026-05-06
FY 2025	$-10.29	2026-02-26
Q3 2025	$-0.05	2025-11-05
Q2 2025	$-0.10	2025-08-06
Q1 2026	$-0.05	2026-05-06
FY 2025	$-1.25	2026-02-26

Full earnings history →

Pharmaceutical Preparations peers

PRGO vs 14 industry peers (Pharmaceutical Preparations), by market cap.

P/S vs peers

0.33 / 3.54 med

-91% discount

Net margin vs peers

-33.5% / -0.1% med

below median

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
VRTX	Vertex Pharmaceuticals	$114.6B	28.99	9.55	32.9%	-1.63%
BMY	Bristol Myers Squibb	$110.3B	15.63	2.29	14.6%	-2.35%
REGN	Regeneron Pharmaceuticals	$63.4B	14.08	4.42	31.4%	+0.38%
ALNY	Alnylam Pharmaceuticals	$36.9B	117.57	9.93	8.4%	-1.66%
TEVA	Teva Pharmaceutical Industries Ltd	$36.6B	25.98	2.12	8.2%	-3.33%
ZTS	Zoetis	$33.1B	12.37	3.49	28.2%	+2.09%
RPRX	Royalty Pharma Plc	$23.1B	30.02	9.73	32.4%	-1.30%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.